Location History:
- San Mateo, CA (US) (2014)
- London, GB (2016)
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Betty Peng
Introduction
Betty Peng is a prominent inventor based in London, GB. She has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). With a total of 2 patents, her work has advanced the understanding of HCV replication and potential antiviral treatments.
Latest Patents
Betty Peng's latest patents include the development of replicons for both genotype 6 and genotype 4 hepatitis C virus. The patent for HCV genotype 6 replicons provides methods for preparing these replicons, which contain adaptive mutations that enhance the virus's capability to replicate in vitro. Additionally, this patent outlines methods for using these replicons to screen antiviral agents. Similarly, her patent for HCV genotype 4 replicons also details the preparation methods and their application in antiviral screening.
Career Highlights
Betty Peng is currently employed at Gilead Sciences, Inc., where she continues her research and development efforts. Her work at Gilead has positioned her as a key player in the fight against hepatitis C, contributing to the development of innovative therapeutic strategies.
Collaborations
Throughout her career, Betty has collaborated with notable colleagues, including William E Delaney, Iv, and Guofeng Cheng. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Betty Peng's contributions to the field of virology, particularly through her patents on hepatitis C virus replicons, highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new antiviral therapies and improved patient outcomes.